Staccato Prochlorperazine in Migraine (Out Patient)
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
Staccato Prochlorperazine is being developed to treat patients suffering from acute migraine
headaches. In October 2005, we completed a 75 patient, multi-center, double-blind
placebo-controlled Phase 2A clinical trial in patients suffering from moderate to severe
acute migraine headaches. This Phase 2B clinical trial of Staccato Prochlorperazine has been
initiated to assess the efficacy and safety in outpatients with migraine headache with or
without aura.